Media Center
Explore our news, press releases, media assets, publications, and official resources
This space brings together all our corporate communications, designed for journalists, partners, healthcare professionals, and stakeholders seeking to stay informed about our latest developments.
Here, you’ll find our most recent press releases, media kits, official publications, visuals, videos, and key resources to better understand our mission, innovations, and global impact in the pharmaceutical field.

July 12, 2022
Provepharm receives FDA approval for BLUDIGO™ (indigotindisulfonate sodium, USP) Injection
See more

July 12, 2022
Provepharm receives FDA marketing approval in US for BLUDIGO (indigotindisulfonate sodium, USP) Injection
See more

November 25, 2021
Provepharm Life Solutions obtains FDA authorization to produce its active ingredients for the United States
See more

September 8, 2021
Provepharm Life Solutions raises €120 million
See more

December 2, 2020
Provepharm Life Solutions acquires Apollo Pharmaceuticals USA to continue growth in the United States
See more

February 12, 2020
Provepharm Life Solutions acquires Apollo Pharmaceuticals USA to continue growth in the United States
See more

September 25, 2019
Provepharm Life Solutions invests €9M in its new pilot production unit
See more

May 9, 2019
Provepharm Life Solutions receives €42M
See more

April 23, 2018
Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest
See more